Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST

Sansure Biotech Statistics

Total Valuation

Sansure Biotech has a market cap or net worth of CNY 8.39 billion. The enterprise value is 6.36 billion.

Market Cap8.39B
Enterprise Value 6.36B

Important Dates

The last earnings date was Thursday, October 29, 2026.

Earnings Date Oct 29, 2026
Ex-Dividend Date Oct 15, 2026

Share Statistics

Sansure Biotech has 568.11 million shares outstanding. The number of shares has decreased by -13.34% in one year.

Current Share Class 568.11M
Shares Outstanding 568.11M
Shares Change (YoY) -13.34%
Shares Change (QoQ) +9.33%
Owned by Insiders (%) 38.79%
Owned by Institutions (%) 9.01%
Float 295.70M

Valuation Ratios

The trailing PE ratio is 77.17 and the forward PE ratio is 33.80.

PE Ratio 77.17
Forward PE 33.80
PS Ratio 5.08
PB Ratio 1.20
P/TBV Ratio 1.51
P/FCF Ratio n/a
P/OCF Ratio 35.03
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 56.99
EV / Sales 3.86
EV / EBITDA 21.19
EV / EBIT 136.68
EV / FCF n/a

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.21.

Current Ratio 4.54
Quick Ratio 4.00
Debt / Equity 0.21
Debt / EBITDA 5.01
Debt / FCF n/a
Interest Coverage 1.73

Financial Efficiency

Return on equity (ROE) is 0.97% and return on invested capital (ROIC) is 0.80%.

Return on Equity (ROE) 0.97%
Return on Assets (ROA) 0.31%
Return on Invested Capital (ROIC) 0.80%
Return on Capital Employed (ROCE) 0.55%
Weighted Average Cost of Capital (WACC) 6.12%
Revenue Per Employee 775,266
Profits Per Employee 52,474
Employee Count2,064
Asset Turnover 0.17
Inventory Turnover 1.05

Taxes

In the past 12 months, Sansure Biotech has paid 13.99 million in taxes.

Income Tax 13.99M
Effective Tax Rate 16.74%

Stock Price Statistics

The stock price has decreased by -32.63% in the last 52 weeks. The beta is 0.49, so Sansure Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.49
52-Week Price Change -32.63%
50-Day Moving Average 15.89
200-Day Moving Average 16.80
Relative Strength Index (RSI) 34.93
Average Volume (20 Days) 3,117,580

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Sansure Biotech had revenue of CNY 1.65 billion and earned 111.66 million in profits. Earnings per share was 0.19.

Revenue1.65B
Gross Profit 1.17B
Operating Income 46.56M
Pretax Income 83.59M
Net Income 111.66M
EBITDA 292.54M
EBIT 46.56M
Earnings Per Share (EPS) 0.19
Full Income Statement

Balance Sheet

The company has 3.62 billion in cash and 1.51 billion in debt, with a net cash position of 2.12 billion or 3.73 per share.

Cash & Cash Equivalents 3.62B
Total Debt 1.51B
Net Cash 2.12B
Net Cash Per Share 3.73
Equity (Book Value) 7.06B
Book Value Per Share 12.26
Working Capital 3.84B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 239.40 million and capital expenditures -350.79 million, giving a free cash flow of -111.39 million.

Operating Cash Flow 239.40M
Capital Expenditures -350.79M
Depreciation & Amortization 245.98M
Net Borrowing 400.11M
Free Cash Flow -111.39M
FCF Per Share -0.20
Full Cash Flow Statement

Margins

Gross margin is 70.95%, with operating and profit margins of 2.82% and 6.77%.

Gross Margin 70.95%
Operating Margin 2.82%
Pretax Margin 5.07%
Profit Margin 6.77%
EBITDA Margin 17.73%
EBIT Margin 2.82%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.53, which amounts to a dividend yield of 3.56%.

Dividend Per Share 0.53
Dividend Yield 3.56%
Dividend Growth (YoY) -2.05%
Years of Dividend Growth 1
Payout Ratio 163.08%
FCF Payout Ratio n/a
Buyback Yield 13.34%
Shareholder Yield 16.90%
Earnings Yield 1.30%
FCF Yield -1.33%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on June 1, 2022. It was a forward split with a ratio of 1.48.

Last Split Date Jun 1, 2022
Split Type Forward
Split Ratio 1.48

Scores

Sansure Biotech has an Altman Z-Score of 3.85 and a Piotroski F-Score of 4.

Altman Z-Score 3.85
Piotroski F-Score 4